Shai Shimony

38PUBLICATIONS

122CO-AUTHORS

Haematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Radiation therapyGene and molecular therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (38)

Sort by Publication Date:

|Jul 07, 2026

Tagraxofusp, Azacitidine, and Venetoclax in Blastic Plasmacytoid Dendritic Cell Neoplasm.

|Apr 20, 2026

The Clinicopathologic and Genomic Features of Mature Versus Blastic Plasmacytoid Dendritic Cell Neoplasms Arising From Chronic Myeloid Neoplasms.

|Feb 24, 2026

Risk stratification of patients with TP53-mutated myeloproliferative neoplasms.

Benjamin Rolles, Cilomar Martins de Oliveira Filho, Nathan Fergusson

|Feb 24, 2026

No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse.

H Moses Murdock, Haesook T Kim, Katie Maurer

|Feb 09, 2026

Obinutuzumab Maintenance in Follicular Lymphoma Is Associated With Better Progression Free Survival and Comparable Toxicity.

Renana Robinson, Tamar Berger, Tzippy Shochat

|Feb 02, 2026

CPX-351 selectively benefits patients with AML and myelodysplasia-related mutations in the pivotal randomized trial.

Shai Shimony, H Moses Murdock, Julia H Keating

Pageof 7

Frequent Collaborators

20 joint publications

Marlise R Luskin

12 joint publications

Daniel J DeAngelo

Jacqueline S Garcia

Richard M Stone

Eric S Winer

Ofir Wolach

Evan C Chen

R Coleman Lindsley

Andrew A Lane

Donna S Neuberg

Frequent Collaborators

20 joint publications

Marlise R Luskin

12 joint publications

Daniel J DeAngelo

9 joint publications

Jacqueline S Garcia

7 joint publications

Richard M Stone